一、被提名人具备上市公司运作的基本知识，熟悉相关法律、行政法规、 规章及其他规范性文件，具有 5 年以上法律、经济、会计、财务、管理或者其他 履行独立董事职责所必需的工作经验。 被提名人已经参加培训并取得证券交易所认可的相关培训证明材料。 二、被提名人任职资格符合下列法律、行政法规和部门规章的要求： 独立董事提名人声明与承诺 提名人浙江西大门新材料股份有限公司董事会，现提名段亚峰为浙江西大门 新材料股份有限公司第四届董事会独立董事候选人，并已充分了解被提名人职业、 学历、职称、详细的工作经历、全部兼职、有无重大失信等不良记录等情况。被 提名人已同意出任浙江西大门新材料股份有限公司第四届董事会独立董事候选 人（参见该独立董事候选人声明）。提名人认为，被提名人具备独立董事任职资 格，与浙江西大门新材料股份有限公司之间不存在任何影响其独立性的关系，具 体声明并承诺如下： （一）《中华人民共和国公司法》关于董事任职资格的规定； （二）《中华人民共和国公务员法》关于公务员兼任职务的规定； （三）中国证监会《上市公司独立董事管理办法》、上海证券交易所自律监 管规则以及公司章程有关独立董事任职资格和条件的相关规定； （四） ...

证券代码：605155 证券简称：西大门 公告编号：2025-025 浙江西大门新材料股份有限公司 关于召开2025年第一次临时股东大会的通知 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 一、 召开会议的基本情况 (四)现场会议召开的日期、时间和地点 召开的日期时间：2025 年 7 月 29 日 15 点 00 分 召开地点：绍兴市柯桥区兰亭街道阮港村浙江西大门新材料股份有限公司会 至2025 年 7 月 29 日 采用上海证券交易所网络投票系统，通过交易系统投票平台的投票时间为股 东大会召开当日的交易时间段，即 9:15-9:25,9:30-11:30，13:00-15:00；通过 互联网投票平台的投票时间为股东大会召开当日的 9:15-15:00。 (六)融资融券、转融通、约定购回业务账户和沪股通投资者的投票程序 涉及融资融券、转融通业务、约定购回业务相关账户以及沪股通投资者 的投票，应按照《上海证券交易所上市公司自律监管指引第 1 号—规范运作》 等有关规定执行。 (七)涉及公开征集股东投票权 无 ...

证券代码：605155 证券简称：西大门 公告编号：2025-023 浙江西大门新材料股份有限公司 第三届监事会第二十二次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、监事会会议召开情况 浙江西大门新材料股份有限公司（以下简称"公司"）第三届监事会第二十 二次会议于 2025 年 7 月 10 日以现场方式召开，会议通知已于 2025 年 7 月 3 日 通过专人送达及邮件方式等送达全体监事。本次会议由监事会主席柏建民主持， 应出席监事 3 名，实际出席监事 3 名。本次会议的召开符合《中华人民共和国 公司法》等法律、行政法规以及《公司章程》的规定，决议内容合法有效。 二、监事会会议审议情况 （一）审议通过了《关于变更公司注册资本、撤销监事会及修订<公司章程>的 议案》 浙江西大门新材料股份有限公司董事会文件 2.公司原注册资本为 13,440 万元，因限制性股票授予和权益分派实施，形 成新股导致注册资本发生变化，本次变更后注册资本为 191,681,000 元。 上述变更内容最终以工商行政管理部门的核 ...

证券代码：605155 证券简称：西大门 公告编号：2025-022 浙江西大门新材料股份有限公司 第三届董事会第二十七次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 一、董事会会议召开情况 浙江西大门新材料股份有限公司（以下简称"公司"）第三届董事会第二十七 次会议于 2025 年 7 月 10 日以现场方式召开，会议通知已于 2025 年 7 月 3 日通 过专人送达及邮件方式等送达全体董事。本次会议由董事长柳庆华主持，应出席 董事 7 名，实际出席董事 7 名。本次会议的召开符合《中华人民共和国公司法》 等法律、行政法规以及《公司章程》的规定，决议内容合法有效。 二、董事会会议审议情况 （一）审议通过了《关于提名公司第四届董事会非独立董事候选人的议案》 本议案在提交董事会前已经公司第三届董事会提名委员会 2025 年第一次会 议审议通过，同意提交董事会审议。 鉴于公司第三届董事会任期届满，根据《公司法》、《公司章程》等有关规 定，经公司董事会提名，经董事会提名委员会对新一届非独立董事候选人进行任 职 ...

Fundraising Overview - The company Zhejiang Xidamen New Materials Co., Ltd. successfully completed its initial public offering (IPO) by issuing 24 million shares at a price of RMB 21.17 per share, raising a total of RMB 508.08 million, with a net amount of RMB 455.91 million after deducting issuance costs of RMB 52.17 million [1][2] Fund Management and Usage - The company established a special account for the management and use of the raised funds, in compliance with relevant laws and regulations, to protect investor rights [1][2] - A tripartite supervision agreement was signed with the underwriter and the banks holding the funds, ensuring proper management and usage of the raised capital [1][2] Account Closure - Due to the completion of certain investment projects funded by the IPO, the company decided to close specific fundraising accounts at Zhejiang Shaoxing Ruifeng Rural Commercial Bank and Industrial and Commercial Bank of China, as the funds in these accounts had been fully utilized [2][3] - The closure of these accounts has been completed, and the company has notified the underwriter and relevant parties [3]

为了规范募集资金的管理和使用，提高资金使用效率和效益，保护投资者 权益，本公司按照《中华人民共和国公司法》《中华人民共和国证券法》《上 市公司监管指引第 2 号——上市公司募集资金管理和使用的监管要求（2022 年 修订）》（证监会公告〔2022〕15 号）和《上海证券交易所上市公司自律监管 指引第 1 号——规范运作（2023 年 12 月修订）》（上证发〔2023〕193 号）等 证券代码：605155 证券简称：西大门 公告编号：2025-021 浙江西大门新材料股份有限公司 关于部分募集资金专户销户完成的公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 浙江西大门新材料股份有限公司（以下简称"公司"）首次公开发行股票 募集资金按照相关法律、法规、规范性文件的规定在银行开立了募集资金专项 账户。鉴于公司首次公开发行股票募集资金部分投资项目已经结项，公司办理 完成了部分募集资金专项账户的注销手续，具体情况如下： 一、 募集资金基本情况 经中国证券监督管理委员会《关于核准浙江西大门新材料股份有限公司首次 公开发 ...

Group 1 - Kaichun Co., Ltd. adjusted the share repurchase price limit from 26.625 yuan/share to 40 yuan/share, effective from June 10, 2025 [1] - Yipin Pharmaceutical's subsidiary received a drug registration certificate for Dexmedetomidine Hydrochloride Injection, a Class 3 chemical drug used for sedation during anesthesia [1] - Bohui Innovation obtained a medical device registration certificate for HPV Genotyping Test Kit, used for qualitative detection of HPV DNA [1][2] Group 2 - Lingyi Zhi Zao's application for issuing convertible bonds and cash payment to acquire 66.46% of Jiangsu Kedasiteng Automotive Technology Co., Ltd. has been accepted by the Shenzhen Stock Exchange [3] - Kemin Food reported a 23.06% year-on-year increase in pig sales in May, with a total of 48,300 pigs sold [4][5] - Meian Sen decided to terminate the issuance of shares to specific objects due to market conditions and strategic considerations [6][7] Group 3 - Zhengbang Technology reported a 146.6% year-on-year increase in pig sales revenue in May, totaling 731 million yuan [9] - Yuanda Holdings plans to reduce the registered capital of its subsidiary from 73 million to 24.3 million USD to optimize asset structure [10] - East China Pharmaceutical's subsidiary received FDA approval for clinical trials of HDM1010 tablets for type 2 diabetes [12] Group 4 - Liangxin Co., Ltd. received a government subsidy of 14.1 million yuan, accounting for 4.52% of its audited net profit for 2024 [13] - Erkang Pharmaceutical's Vitamin B6 Injection passed the consistency evaluation for generic drugs [14] - New Industry received a patent certificate for an antibody related to anti-PIC detection, enhancing detection efficiency [16][15] Group 5 - Dongxing Medical signed a 6 million yuan technology development contract with Shanghai Jiao Tong University for collagen preparation processes [16] - Suchang Chai A's subsidiary will absorb and merge another subsidiary, adjusting internal equity structure [17] - Yibin Technology received a project designation notice from a domestic new energy vehicle company, with an estimated total sales of 256 million yuan over five years [18] Group 6 - Mingchen Health received a cash dividend of 20 million yuan from its subsidiary [19] - Hendi Pharmaceutical obtained a drug registration certificate for Ibuprofen Suspension, a common medication for children [19] - Huaren Pharmaceutical's subsidiary received a drug registration certificate for Dexmedetomidine Hydrochloride Injection, classified as a Category B drug under national medical insurance [20] Group 7 - Enwei Pharmaceutical obtained a renewed drug production license for six key products [21] - Xiaoming Co., Ltd. reported a 45.59% year-on-year increase in chicken product sales in May, totaling 23.25 million birds [23][24] - Shan Natural Gas successfully issued a 350 million yuan short-term financing bond with a 1.78% interest rate [25] Group 8 - Xidamen announced plans for board members to reduce their holdings by up to 581,000 shares [26] - Shentong Technology's shareholder plans to reduce holdings by up to 3% of the company's shares [27] - Saintno Bio plans to distribute a cash dividend of 0.14 yuan per share and a capital increase of 0.4 shares per share [28] Group 9 - *ST King Kong's subsidiary received a debt transfer notice from its controlling shareholder, totaling 364 million yuan [29] - Foxit Software's executives plan to reduce their holdings by a total of 55,800 shares [30] - Youyou Green Energy plans to apply for a bank credit line of up to 1.5 billion yuan [31] Group 10 - Guoxing Optoelectronics plans to distribute a cash dividend of 0.5 yuan per 10 shares [32] - Guangxun Technology plans to distribute a cash dividend of 2.6 yuan per 10 shares [33] - Hanrui Cobalt plans to distribute a cash dividend of 1.5 yuan per 10 shares [35] Group 11 - Tigermed plans to distribute a cash dividend of 3 yuan per 10 shares [37] - Shenliang Holdings plans to distribute a cash dividend of 1.5 yuan per 10 shares [38] - Yishitong plans to distribute a cash dividend of 1 yuan per 10 shares [39]

Group 1 - Controlling shareholders of Lian De Equipment plan to reduce their holdings by up to 5,401,529 shares, accounting for 3.00% of the total share capital within three months [1] - Controlling shareholders of Doctor Glass plan to reduce their holdings by up to 4,718,494 shares, accounting for 2.69% of the total share capital within three months [1] - Controlling shareholder of Ben Chuan Intelligent plans to reduce their holdings by up to 2,318,900 shares, accounting for 3.00% of the total share capital within three months [1] Group 2 - Shareholder of Hubei Broadcasting plans to reduce their holdings by up to 11,371,400 shares, accounting for 1.00% of the total share capital within three months [1] - Shareholder of Weixing Intelligent plans to reduce their holdings by up to 30,400 shares, accounting for 0.01% of the total share capital within three months [1] Group 3 - Director of Tianzhou Culture plans to reduce their holdings by up to 9,485,100 shares, accounting for 1.16% of the total share capital within three months [2] - Shareholder of Hongbo Pharmaceutical plans to reduce their holdings by up to 1,370,000 shares, accounting for 1.00% of the total share capital after excluding repurchased shares [2] - Shareholder of Oujing Technology plans to reduce their holdings by up to 577,220 shares, accounting for 3.00% of the total share capital within three months [2] Group 4 - Shareholders of Longhua New Materials plan to reduce their holdings by up to 990,000 shares and 61,000 shares, accounting for 0.2302% and 0.0142% of the total share capital respectively within three months [2] Group 5 - Shareholder of Desai Xiwai plans to reduce their holdings by up to 16,400,000 shares, accounting for 3.00% of the total share capital within three months [3] - Shareholder of Tongyou Technology plans to reduce their holdings by up to 4,792,637 shares, accounting for 1.00% of the total share capital within three months [3] - Shareholders of Xice Testing plan to reduce their holdings by a total of 592,000 shares, accounting for 0.7014% of the total share capital within three months [3] Group 6 - Director of Kede Education plans to reduce their holdings by up to 1,501,875 shares, accounting for 0.4563% of the total share capital within three months [3] - Shareholder of Jianke Institute plans to reduce their holdings by up to 1,466,600 shares, accounting for 1.00% of the total share capital within three months [4] - Shareholder of Ruantong Power plans to reduce their holdings by up to 9,529,300 shares, accounting for 1.00% of the total share capital within three months [4] Group 7 - Shareholder of Tianli Lithium Energy has not reduced their holdings during the specified period [4] - Shareholders of Dongli Machinery plan to reduce their holdings by up to 4,330,534 shares, accounting for 3.00% of the total share capital within three months [4] - Shareholders of Zhongzhou Holdings plan to reduce their holdings by a total of 8,357,544 shares, accounting for 4.999998% of the total share capital [5] Group 8 - Shareholder of Online and Offline plans to reduce their holdings by up to 2,000,000 shares, accounting for 2.51% of the total share capital after excluding repurchased shares [5] - Shareholders of Puli Software plan to reduce their holdings by up to 1,957,500 shares, accounting for 0.70% of the total share capital within three months [5] - Shareholder of Yisheng Pharmaceutical plans to reduce their holdings by up to 416,179 shares, accounting for 0.1258% of the total share capital within three months [5] Group 9 - Shareholders of Gaomeng New Materials plan to reduce their holdings by up to 9,834,608 shares, accounting for 2.282% of the total share capital within three months [6] - Shareholder of Wenke Co. plans to reduce their holdings by up to 9,639,121 shares, accounting for 1.60% of the total share capital within three months [6] - Shareholder of Nanling Technology plans to reduce their holdings by a total of 197,400 shares, accounting for 0.1499% of the total share capital [6] Group 10 - Shareholders of Tianfang Biao plan to reduce their holdings through various methods, with total reductions accounting for 1.00% of the total share capital [6] - Shareholders of Shenyu Co. plan to reduce their holdings by up to 1,747,700 shares, accounting for 0.99% of the total share capital within three months [7] - Shareholder of Jindan Technology plans to reduce their holdings by up to 563,500 shares, accounting for 2.93% of the total share capital within three months [7] Group 11 - Shareholder of Bochuang Technology plans to reduce their holdings by up to 1,710,000 shares, accounting for 0.59% of the total share capital within three months [7] - Shareholder of Chuangwei Digital plans to reduce their holdings by a total of 9,000,000 shares, accounting for 0.788% of the total share capital within three months [8] - Shareholders of Keri International plan to reduce their holdings by various amounts, with total reductions accounting for 0.0238% to 0.1059% of the total share capital [8] Group 12 - Shareholders of Xingchen Technology plan to reduce their holdings by up to 10,526,500 shares, accounting for 2.5% of the total share capital within three months [9] - Shareholder of Changyang Technology plans to reduce their holdings by up to 1,920,000 shares, accounting for 0.67% of the total share capital within three months [9] - Shareholders of Fuxin Software plan to reduce their holdings by various amounts, with total reductions accounting for 0.0547% to 0.0063% of the total share capital [10] Group 13 - Shareholder of Hainan Haiyao plans to reduce their holdings by 15,573,600 shares, accounting for 1.2004% of the total share capital [10] - Shareholder of Ruoyuchen plans to reduce their holdings by up to 4,768,071 shares, accounting for 3.00% of the total share capital within three months [10] - Shareholders of Fuxin Technology plan to reduce their holdings by various amounts, with total reductions accounting for 1.4959% to 0.0198% of the total share capital [11] Group 14 - Shareholder of Liming Co. plans to reduce their holdings by various amounts, with total reductions accounting for 0.43% to 0.07% of the total share capital [11] - Shareholder of Huazhu High-Tech plans to reduce their holdings by up to 9,111,714 shares, accounting for 2.20% of the total share capital within three months [11] - Shareholder of Yongda Co. plans to reduce their holdings by up to 7,200,000 shares, accounting for 3.00% of the total share capital within three months [12] Group 15 - Shareholder of Del Shares plans to reduce their holdings by up to 3,000,000 shares, accounting for 1.987% of the total share capital within three months [12] - Shareholder of Artis plans to reduce their holdings by up to 36,882,173 shares through various methods, accounting for 1% of the total share capital [12] - Shareholder of Xidamen plans to reduce their holdings by various amounts, with total reductions accounting for 0.1955% to 0.0402% of the total share capital [13] Group 16 - Shareholder of Huicheng Vacuum plans to reduce their holdings by up to 2,500,000 shares, accounting for 2.50% of the total share capital within three months [13] - Shareholder of Shentong Technology plans to reduce their holdings by up to 12,880,640 shares, accounting for 3.00% of the total share capital within three months [13] - Shareholder of Mindong Electric Power plans to reduce their holdings by up to 4,579,514 shares, accounting for 1.00% of the total share capital within the specified period [14] Group 17 - Shareholders of Juxin Technology plan to reduce their holdings by various amounts, with total reductions accounting for 1.00% of the total share capital [14] - Shareholder of Zhonggu Logistics plans to reduce their holdings by up to 2.45% and 0.55% of the total share capital within three months [15] - Shareholder of Aotai Bio plans to reduce their holdings by up to 388,400 shares, accounting for 0.4899% of the total share capital [15] Group 18 - Shareholder of Guotai Group plans to reduce their holdings by up to 0.266% of the total share capital within three months [15] - Shareholder of Shanghai Construction plans to reduce their holdings by up to 24,419,665 shares, accounting for 0.27% of the total share capital within the specified period [16]

Group 1 - The company Zhejiang Xidamen New Materials Co., Ltd. announced a share reduction plan by its directors and senior management [1][2] - The total number of shares to be reduced is up to 581,000 shares, accounting for approximately 0.3033% of the company's total share capital [2] - The reduction period is set for three months starting from 15 trading days after the announcement, excluding any periods where reductions are prohibited [2] Group 2 - The directors and senior management involved in the reduction include Shen Huafeng, Liu Ying, Bai Jianmin, Zhou Li, and Dong Yuting, with specific shareholding percentages detailed [1][2] - The planned reduction amounts for each individual are specified, with Shen Huafeng and Liu Ying planning to reduce 374,500 shares and 77,000 shares respectively [2] - The reduction will be conducted through centralized bidding, and the price will be determined based on market conditions at the time of the reduction [2][3]

证券代码：605155 证券简称：西大门 公告编号：2025-020 浙江西大门新材料股份有限公司 董监高减持股份计划公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 董监高持股的基本情况:浙江西大门新材料股份有限公司（以下简称"公 司"）董事兼副总经理沈华锋先生、柳英女士分别持有公司股份 1,498,000 股、 308,000 股，分别占公司股份总数的 0.7821%、0.1608%；监事柏建民先生直接持 有公司股份 98,000 股，占公司股份总数的 0.0512%；高级管理人员周莉女士、董 雨亭女士分别持有公司股份 308,000 股、112,000 股，分别占公司股份总数的 0.1608%、0.0585%。 减持计划的主要内容：减持期间为自本公告披露之日起 15 个交易日后的 未来 3 个月内（根据中国证监会及上海证券交易所规定禁止减持的期间除外）。 公司董事兼副总经理沈华锋先生、柳英女士计划通过集中竞价交易方式减持公司 股份，减持数量分别不超过 374,500 股、77,00 股；监事 ...